Bottom line
MHELX vs FSSNX: the short answer
MHELX (MH Elite Small Cap Fund of Funds) and FSSNX (Fidelity Small Cap Index Fund) are both mutual funds.
But FSSNX is far broader, holding 1,966 positions to 13 for MHELX, so beyond the top names it adds exposure MHELX doesn't have.
FSSNX is cheaper at 0.025% vs 2.13% — a difference of $211 a year per $10,000 invested.
Over five years, FSSNX returned +6.2% a year vs +5.9% for MHELX (reporting dates differ).
Updated Nov 19, 2026
MHELX vs FSSNX side by side
| MHELX | FSSNX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Mh Elite Of | Fidelity |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 2.13% | 0.025% |
| Annual cost per $10k | $213 | $2.5 |
| 10-yr cost on $10k (prospectus) | $2,746 | $32 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +11.5% | +12.9% |
| 5-yr return (annualized) | +5.9% | +6.2% |
| 10-yr return (annualized) | +8.6% | +9.8% |
| Best quarter | +27.2% | +31.3% |
| Worst quarter | −27.8% | −30.6% |
| Net assets (fund) | $14.9M | $34.1B |
| Number of holdings | 13 | 1,966 |
| Portfolio turnover | 22% | 2% |
| Returns as of | Dec 31, 2025 | Jun 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MHELX and FSSNX share none of their top holdings.
MHELX top 10
- Oberweis Funds — 11.81%
- Manager Directed Portfolios — 9.94%
- Invesco Sector — 9.29%
- Aegis Funds — 9.11%
- Vanguard Index Funds — 7.74%
- Professionally Managed Portfolios — 7.64%
- Fidelity Capital Trust — 7.27%
- Capitol Series Trust — 6.80%
- James Advantage Funds — 6.32%
- Vanguard Index Funds — 6.04%
FSSNX top 10
- Fidelity Revere Street Trust — 8.41%
- Fidelity Revere Street Trust — 0.41%
- Moog Inc — 0.36%
- Hut 8 Corp — 0.36%
- Umb Financial Corp — 0.35%
- Cytokinetics Inc — 0.33%
- Viasat Inc — 0.31%
- Brightspring Health Services Inc — 0.31%
- Glaukos Corp — 0.31%
- Caretrust REIT Inc — 0.31%
FAQ
What is the difference between MHELX and FSSNX?
Which is cheaper, MHELX or FSSNX?
Should I own both MHELX and FSSNX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.